Perfil
Albert Osterhaus was the founder of ViroClinics Biosciences BV, founded in 2001, holding the title of Chief Scientific Officer.
Mr. Osterhaus is also the founder of Clinical Research Rotterdam BV.
Mr. Osterhaus is currently a Professor at Erasmus University Rotterdam and a Professor at the University of Utrecht.
Cargos activos de Albert Osterhaus
| Empresas | Cargo | Inicio |
|---|---|---|
Erasmus University Rotterdam
Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Clinical Research Rotterdam BV
Clinical Research Rotterdam BV Medical/Nursing ServicesHealth Services Operates clinical research center | Fundador | - |
Antiguos cargos conocidos de Albert Osterhaus.
| Empresas | Cargo | Fin |
|---|---|---|
ViroClinics Biosciences BV
ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology Operates diagnostic and clinical trial services | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Erasmus University Rotterdam
Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViroClinics Biosciences BV
ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology Operates diagnostic and clinical trial services | Health Technology |
Clinical Research Rotterdam BV
Clinical Research Rotterdam BV Medical/Nursing ServicesHealth Services Operates clinical research center | Health Services |
- Bolsa de valores
- Insiders
- Albert Osterhaus
















